Genetron Holdings Limited
GTH · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | -0.55 | 2.85 | 2.32 |
| FCF Yield | -75.54% | -5.70% | -2.12% | -0.96% |
| EV / EBITDA | -1.08 | -22.03 | -75.69 | -36.77 |
| Quality | ||||
| ROIC | -96.10% | -32.45% | -0.90% | -36.85% |
| Gross Margin | 43.25% | 63.53% | 61.30% | 44.83% |
| Cash Conversion Ratio | 0.57 | 1.04 | 0.10 | 0.29 |
| Growth | ||||
| Revenue 3-Year CAGR | 15.30% | 18.04% | 23.53% | 47.38% |
| Free Cash Flow Growth | 11.10% | -73.84% | -57.69% | 10.43% |
| Safety | ||||
| Net Debt / EBITDA | 0.03 | 1.23 | 6.21 | 0.12 |
| Interest Coverage | -5.67 | -91.57 | -45.06 | -56.77 |
| Efficiency | ||||
| Inventory Turnover | 8.70 | 5.45 | 6.58 | 9.97 |
| Cash Conversion Cycle | 161.00 | 228.55 | 158.92 | 53.33 |